UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells Journal article
SCIENTIFIC REPORTS, 2017,Volume: 7
Authors:  Zhang, Jinming;  Wang, Lu;  Chan, Hon Fai;  Xie, Wei;  Chen, Sheng;  He, Chengwei;  Wang, Yitao;  Chen, Meiwan
View  |  Adobe PDF(1919Kb)  |  Favorite  |  View/Download:301/9  |  Submit date:2018/10/30
Revisiting Non-Cancer Drugs for Cancer Therapy Journal article
Current Topics in Medicinal Chemistry, 2016,Volume: 16,Issue: 19,Page: 2144-2155
Authors:  Yang E.J.;  Wu C.;  Liu Y.;  Lv J.;  Shim J.S.
Favorite  |  View/Download:5/0  |  Submit date:2019/01/15
Cancer  Disulfiram  Doxycycline  Drug Repositioning  Existing Drugs  Mebendazole  Pyrvinium Pamoate  Triclosan  
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth Journal article
Prostate, 2011,Volume: 71,Issue: 4,Page: 333-343
Authors:  Lin J.;  Haffner M.C.;  Zhang Y.;  Lee B.H.;  Brennen W.N.;  Britton J.;  Kachhap S.K.;  Shim J.S.;  Liu J.O.;  Nelson W.G.;  Yegnasubramanian S.;  Carducci M.A.
Favorite  |  View/Download:1/0  |  Submit date:2019/01/15
Disulfiram  DNA methylation  DNA methyltransferase inhibitor  Prostate cancer